Clinical Trial Update: Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial evaluating ranibizumab alone or with laser photocoagulation versus laser alone in proliferative diabetic retinopathy; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Proliferative Diabetic Retinopathy (PDR) | Phase 2 | Status: COMPLETED | Results posted: 2019-03-15